Viewing Study NCT00927459


Ignite Creation Date: 2025-12-24 @ 2:28 PM
Ignite Modification Date: 2025-12-27 @ 12:07 AM
Study NCT ID: NCT00927459
Status: TERMINATED
Last Update Posted: 2010-01-22
First Post: 2009-06-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Liposomal siRNA in Subjects With High Cholesterol
Sponsor: Arbutus Biopharma Corporation
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module